POROKERATOSIS

This adverse event was reported 184 times

POROKERATOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IMIQUIMOD 2 0.0009
1 PIOGLITAZONE HYDROCHLORIDE 1 0.0008
2 NICARDIPINE HYDROCHLORIDE 1 0.0004
3 CICLOPIROX 1 0.0004
4 BARICITINIB 1 0.0003
5 BLEOMYCIN SULFATE 3 0.0003
6 OLAPARIB 6 0.0003
7 DURVALUMAB 6 0.0003
8 HYDROXYZINE PAMOATE 1 0.0003
9 TRETINOIN 2 0.0002
See all drugs enriched for association with POROKERATOSIS